• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Mahidol University - Developmental Therapeutics Review - Q1 2011 Product Image

Mahidol University - Developmental Therapeutics Review - Q1 2011

  • ID: 1447219
  • March 2011
  • 38 pages
  • Global Markets Direct

Mahidol University – Developmental Therapeutics Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Mahidol University – Developmental Therapeutics Review – Q1 2011” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Mahidol University.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Mahidol University with complete description of the product’s READ MORE >



List of Tables
List of Figures
Mahidol University Snapshot
Mahidol University Overview
Key Information
Key Facts
Mahidol University – Research and Development Overview
Key Therapeutic Areas
Mahidol University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Mahidol University – Pipeline Products Glance
Mahidol University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Mahidol University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Mahidol University – Drug Profiles
Albendazole for Chronic Strongyloidiasis
Product Description
Mechanism of Action
R&D Progress
Budesonide
Product Description
Mechanism of Action
R&D Progress
Capsaicin Nanoparticle Cream
Product Description
Mechanism of Action
R&D Progress
Curcuma Domestica Extracts
Product Description
Mechanism of Action
R&D Progress
Curcumin
Product Description
Mechanism of Action
R&D Progress
Derris Scandens Benth Extracts
Product Description
Mechanism of Action
R&D Progress
Ivermectin
Product Description
Mechanism of Action
R&D Progress
Nebulized Colistin
Product Description
Mechanism of Action
R&D Progress
Simvastatin
Product Description
Mechanism of Action
R&D Progress
Sorafenib
Product Description
Mechanism of Action
R&D Progress
Alemtuzumab
Product Description
Mechanism of Action
R&D Progress
Camella Sinensis
Product Description
Mechanism of Action
R&D Progress
Gemcitabine + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Ipomea pes-caprae ointment
Product Description
Mechanism of Action
R&D Progress
Sorafenib + Gemcitabine
Product Description
Mechanism of Action
R&D Progress
Yt90-Zevalin
Product Description
Mechanism of Action
R&D Progress
Mahidol University – Pipeline Analysis
Mahidol University – Pipeline Products by Therapeutic Class
Mahidol University - Pipeline Products By Target
Mahidol University – Pipeline Products by Route of Administration
Mahidol University – Pipeline Products by Molecule Type
Mahidol University - Dormant Projects
Mahidol University - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Desmopressin + Dexamethasone
Mahidol University – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos